The SIBO diagnostics market was valued at US$ 138,324.23 thousand in 2020, and it is projected to reach US$ 194,604.51 thousand by 2028; it is expected to grow at a CAGR of 4.4% from 2021 to 2028.
Small intestinal bacterial overgrowth (SIBO) is commonly seen in the presence of one or more predisposing conditions. It varies highly based on the underlying disorders and microbiota characteristics of patients and organisms. SIBO results in gastrointestinal IBS-like symptoms, which could be asymptomatic. In worse cases, it may result in real malabsorption syndrome. The presence of SIBO is generally diagnosed with hydrogen lactulose and glucose breath tests. These tests are widely performed in every clinical setting due to their low costs, non-invasively, sufficient accuracy, and reproducibility.
The SIBO diagnostics market is segmented on the basis of diagnosis, type, and geography. Based on geography, the market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the SIBO diagnostics market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the world. It also includes COVID-19 impact analysis across all the regions. It is estimated that the market is likely to have slower growth rate during the forecast period owing to the restricted health services and lockdown situation caused by COVID-19 pandemic.
Lucrative Regions for SIBO Diagnostics Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Increasing Prevalence of Irritable Bowel Syndrome (IBS) and SIBO
Irritable bowel syndrome (IBS) is the commonly diagnosed gastrointestinal disorder with abdominal pain and altered bowel habits resulting with associated symptoms such as bloating, malabsorption, and systemic symptoms. The incidences of IBS are increasing at a significant rate across the world. According to a research article, ‘Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study’ published by Elsevier Inc. in 2021, most countries have a prevalence rate of 2–6%. Countries such as Japan, China, Russia, South Africa, and the US have a prevalence rate of 2.2%, 2.3%, 5.9%, 5.9%, and 5.3%, respectively. The increasing prevalence of IBS across the world is due to the changing lifestyle and dietary habits. Small intestinal bacterial overgrowth (SIBO) is widely associated with the IBS.
Likewise, SIBO shows similar symptoms to IBS. Technological developments have now allowed the diagnosis of SIBO while diagnosing IBS. Therefore, the prevalence of SIBO is widely understood and reported worldwide. For instance, according to an article, ’Small Intestinal Bacterial Overgrowth: A Case-Based Review’ published in the Journal of Patient-Centered Research and Reviews (JPCRR) in November 2015, 30–85% of adult patients with IBS are likely to develop SIBO. Similarly, according to the recent data published in 2020 by the American College of Gastroenterology, ~78% of IBS patients are living with SBIO; hence, it is a predominantly evaluated condition. It is, therefore, estimated that the prevalence of IBS and SIBO will grow significantly in the near future, leading to the increasing diagnosis and eventual market growth.
Diagnosis-Based Insights
Based on diagnosis, the SIBO diagnostics market is segmented into breath testing, small intestine aspirate and fluid culture test, blood test, and others. In 2020, the breath testing segment held the largest share of the market, and is also expected to grow at the fastest rate in the coming years. The growth is attributed due to its advantages, such as non-invasive, patient-friendly, simplicity, and low-cost
Global SIBO Diagnostics Market, by Diagnosis – 2020 & 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Type-Based Insights
Based on type, the SIBO diagnostics market is segmented into hydrogen-predominant SIBO, methane-predominant SIBO, and recurrent SIBO. In 2020, the hydrogen-predominant SIBO segment held the largest share of the market, and the same segment is expected to grow at the fastest rate during the coming years.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market: Strategic Insights
Market Size Value in US$ 138,324.23 thousand in 2020 Market Size Value by US$ 194,604.51 thousand by 2028 Growth rate CAGR of 4.4% from 2021-2028 Forecast Period 2021-2028 Base Year 2021
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market: Strategic Insights
| Market Size Value in | US$ 138,324.23 thousand in 2020 |
| Market Size Value by | US$ 194,604.51 thousand by 2028 |
| Growth rate | CAGR of 4.4% from 2021-2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Organic strategies such as product launch, are commonly adopted by the market players to meet the changing customer demand and maintain their improved services. For instance, in February 2020, Commonwealth Diagnostics International (CDI), Inc., announced the commercial re-launch of IBSchek, the first clinically validated biomarker blood test for diarrhea-predominant and mixed-type Irritable Bowel Syndrome (IBS-D, IBS-M) in a new at-home capillary collection kit.
By Diagnostics
- Breath Testing
- 14C Xylose Breath Test
- Hydrogen Breath Tests
- 14C Glycocholic Acid Breath Test
- Malabsorption Tests
- Small Intestine Aspirate and Fluid Culture Test
- Blood Test
- Others
By Type
- Hydrogen-predominant SIBO
- Methane-predominant SIBO
- Recurrent SIBO
By Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
South and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- Genova Diagnostics
- SIBO Diagnostics
- Commonwealth Diagnostics International
- Aerodiagnostics, LLC
- SIBOTest
- Metabolic Solutions, Inc.
- Pivotal Diagnostics
- DirectLabs, LLC
- Vibrant Wellness
- Health Associates Medical Group
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Diagnosis ; Type , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Small intestinal bacterial growth (SIBO) is commonly seen in the presence of one or more predisposing conditions. It varies highly based on the underlying disorders and microbiota characteristics of patients and organisms. SIBO results in gastrointestinal IBS-like symptoms, which could be asymptomatic. In worse cases, it may result in real malabsorption syndrome. The presence of SIBO is generally diagnosed with hydrogen lactulose and glucose breath tests. These tests are widely performed in every clinical setting due to their low costs, non-invasively, sufficient accuracy, and reproducibility.
Key factors that are driving growth of the market are increasing incidence of IBS and SIBO and advantages offered by breath tests. However, limitation of diagnostics is a key factor restraining the market growth.
The cost is based on the type of diagnostics test. For instance, the hydrogen breath test is much cheaper than any other test. The cost of the test ranges from US$ 145–US$ 400. Likewise, the cost of endoscopy is ~US$ 135.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – By Diagnosis
1.3.2 Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – By Type
1.3.3 Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – By Geography
2. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 APAC PEST Analysis
4.2.4 MEA PEST Analysis
4.2.5 SCAM PEST Analysis
4.3 Expert Opinion
5. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Prevalence of Irritable Bowel Syndrome (IBS) and SIBO
5.1.2 Advantages of Breath Test
5.2 Key Market Restraints
5.2.1 Limitations of Diagnosis
5.3 Key Market Opportunities
5.3.1 Capsule Technology
5.4 Future Trends
5.4.1 Next-Generation Sequencing (NGS) Technologies to Diagnose SIBO
5.5 Impact Analysis
6. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Global Analysis
6.1 Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Revenue Forecast and Analysis
6.2 Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Analysis– by Diagnosis
7.1 Overview
7.2 Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis 2020 & 2028 (%)
7.3 Breath Testing
7.3.1 Overview
7.3.2 Breath Testing: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
7.3.3C Xylose Breath Test
7.3.3.1 Overview
7.3.3.2C Xylose Breath Test: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
7.3.4 Hydrogen Breath Tests
7.3.4.1 Overview
7.3.4.2 Hydrogen Breath Tests: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
7.3.5C Glycocholic Acid Breath
7.3.5.1 Overview
7.3.5.2C Glycocholic Acid Breath: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
7.3.6 Malabsorption Tests
7.3.6.1 Overview
7.3.6.2 Malabsorption Tests: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
7.4 Small Intestine Aspirate and Fluid Culture Test
7.4.1 Overview
7.4.2 Small Intestine Aspirate and Fluid Culture Test: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
7.5 Blood Test
7.5.1 Overview
7.5.2 Blood Test: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
7.6 Others
7.6.1 Overview
7.6.2 Others: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
8. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Analysis– by Type
8.1 Overview
8.2 Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type 2020 & 2028 (%)
8.3 Hydrogen-predominant SIBO
8.3.1 Overview
8.3.2 Hydrogen-predominant SIBO: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
8.4 Methane-predominant SIBO
8.4.1 Overview
8.4.2 Methane-predominant SIBO: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
8.5 Recurrent SIBO
8.5.1 Overview
8.5.2 Recurrent SIBO: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
9. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Geographical Analysis
9.1 North America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market
9.1.1 Overview
9.1.2 North America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market - Revenue and Forecast to 2028 (USD Thousand)
9.1.3 North America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.1.3.1 North America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.1.4 North America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
9.1.5 North America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Country, 2020 & 2028 (%)
9.1.6 US: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.1.6.1 US: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.1.6.2 US: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.1.6.2.1 US: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.1.6.3 US: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
9.1.7 Canada: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.1.7.1 Canada: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.1.7.2 Canada: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.1.7.2.1 Canada: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.1.7.3 Canada: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
9.1.8 Mexico: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.1.8.1 Mexico: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.1.8.2 Mexico: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.1.8.2.1 Mexico: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.1.8.3 Mexico: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
9.2 Europe: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market
9.2.1 Overview
9.2.2 Europe: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market - Revenue and Forecast to 2028 (USD Thousand)
9.2.3 Europe: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.2.3.1 Europe: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.2.4 Europe: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
9.2.5 Europe: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Country, 2020 & 2028 (%)
9.2.6 Germany: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.2.6.1 Germany: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.2.6.2 Germany: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.2.6.2.1 Germany: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.2.6.3 Germany: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
9.2.7 UK: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.2.7.1 UK: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.2.7.2 UK: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.2.7.2.1 UK: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.2.7.3 UK: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
9.2.8 France: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.2.8.1 France: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.2.8.2 France: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.2.8.2.1 France: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.2.8.3 France: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
9.2.9 Italy: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.2.9.1 Italy: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.2.9.2 Italy: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.2.9.2.1 Italy: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.2.9.3 Italy: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
9.2.10 Spain: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.2.10.1 Spain: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.2.10.2 Spain: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.2.10.2.1 Spain: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.2.10.3 Spain: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
9.2.11 Rest of Europe: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.2.11.1 Rest of Europe: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.2.11.2 Rest of Europe: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.2.11.2.1 Rest of Europe: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.2.11.3 Rest of Europe: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
9.3 Asia-Pacific: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market
9.3.1 Overview
9.3.2 Asia Pacific: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market - Revenue and Forecast to 2028 (USD Thousand)
9.3.3 Asia Pacific: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.3.3.1 Asia Pacific: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.3.4 Asia Pacific: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
9.3.5 Asia Pacific: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Country, 2020 & 2028 (%)
9.3.6 Japan: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.3.6.1 Japan: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.3.6.2 Japan: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.3.6.2.1 Japan: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.3.6.3 Japan: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
9.3.7 China: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.3.7.1 China: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.3.7.2 China: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.3.7.2.1 China: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.3.7.3 China: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
9.3.8 India: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.3.8.1 India: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.3.8.2 India: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.3.8.2.1 India: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.3.8.3 India: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
9.3.9 Australia: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.3.9.1 Australia: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.3.9.2 Australia: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.3.9.2.1 Australia: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.3.9.3 Australia: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
9.3.10 South Korea: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.3.10.1 South Korea: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.3.10.2 South Korea: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.3.10.2.1 South Korea: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.3.10.3 South Korea: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
9.3.11 Rest of Asia-Pacific: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.3.11.1 Rest of Asia Pacific: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.3.11.2 Rest of Asia Pacific: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.3.11.2.1 Rest of Asia Pacific: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.3.11.3 Rest of Asia Pacific: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
9.4 Middle East and Africa: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market
9.4.1 Overview
9.4.2 Middle East and Africa: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market - Revenue and Forecast to 2028 (USD Thousand)
9.4.3 Middle East and Africa: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.4.3.1 Middle East and Africa: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.4.4 Middle East and Africa: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
9.4.5 Middle East and Africa: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Country, 2020 & 2028 (%)
9.4.6 Saudi Arabia: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.4.6.1 Saudi Arabia: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.4.6.2 Saudi Arabia: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.4.6.2.1 Saudi Arabia: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.4.6.3 Saudi Arabia: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
9.4.7 UAE: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.4.7.1 UAE: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.4.7.2 UAE: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.4.7.2.1 UAE: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.4.7.3 UAE: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
9.4.8 South Africa: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.4.8.1 South Africa: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.4.8.2 South Africa: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.4.8.2.1 South Africa: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.4.8.3 South Africa: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
9.4.9 Rest of Middle East and Africa: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.4.9.1 Rest of Middle East and Africa: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.4.9.2 Rest of Middle East and Africa: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.4.9.2.1 Rest of Middle East and Africa: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.4.9.3 Rest of Middle East and Africa: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
9.5 South and Central America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market
9.5.1 Overview
9.5.2 South and Central America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market - Revenue and Forecast to 2028 (USD Thousand)
9.5.3 South and Central America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.5.3.1 South and Central America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.5.4 South and Central America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
9.5.5 South and Central America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Country, 2020 & 2028 (%)
9.5.6 Brazil: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.5.6.1 Brazil: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.5.6.2 Brazil: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.5.6.2.1 Brazil: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.5.6.3 Brazil: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
9.5.7 Argentina: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.5.7.1 Argentina: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.5.7.2 Argentina: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.5.7.2.1 Argentina: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.5.7.3 Argentina: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
9.5.8 Rest of South and Central America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.5.8.1 Rest of South and Central America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.5.8.2 Rest of South and Central America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.5.8.2.1 Rest of South and Central America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.5.8.3 Rest of South and Central America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
10. Impact of COVID-19 Pandemic on Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
10.5 South and Central America: Impact Assessment of COVID-19 Pandemic
11. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market– Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.4 Organic Developments
11.4.1 Overview
11.5 Inorganic Developments
11.5.1 Overview
12. Company Profiles
12.1 Genova Diagnostics
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 SIBO Diagnostics
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Commonwealth Diagnostics International
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Aerodiagnostics, LLC.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 SIBOTest
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Metabolic Solutions, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Pivotal Diagnostics
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 DirectLabs, LLC.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Vibrant Wellness
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Health Associates Medical Group
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 2. North America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 3. North America: Small Intestinal Bacterial Overgrowth (SIBO) diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 4. US: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 5. US: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 6. US: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 7. Canada: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 8. Canada: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 9. Canada: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 10. Mexico: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 11. Mexico: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 12. Mexico: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 13. Europe: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 14. Europe: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 15. Europe: Small Intestinal Bacterial Overgrowth (SIBO) diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 16. Germany: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 17. Germany: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 18. Germany: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 19. UK: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 20. UK: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 21. UK: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 22. France: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 23. France: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 24. France: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 25. Italy: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 26. Italy: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 27. Italy: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 28. Spain: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 29. Spain: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 30. Spain: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 31. Rest of Europe: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 32. Rest of Europe: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 33. Rest of Europe: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 34. Asia Pacific: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 35. Asia Pacific: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 36. Asia Pacific: Small Intestinal Bacterial Overgrowth (SIBO) diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 37. Japan: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 38. Japan: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 39. Japan: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 40. China: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 41. China: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 42. China: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 43. India: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 44. India: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 45. India: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 46. Australia: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 47. Australia: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 48. Australia: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 49. South Korea: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 50. South Korea: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 51. South Korea: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 52. Rest of Asia Pacific: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 53. Rest of Asia Pacific: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 54. Rest of Asia Pacific: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 55. Middle East and Africa: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 56. Middle East and Africa: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 57. Middle East and Africa: Small Intestinal Bacterial Overgrowth (SIBO) diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 58. Saudi Arabia: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 59. Saudi Arabia: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 60. Saudi Arabia: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 61. UAE: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 62. UAE: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 63. UAE: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 64. South Africa: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 65. South Africa: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 66. South Africa: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 67. Rest of Middle East and Africa: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 68. Rest of Middle East and Africa: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 69. Rest of Middle East and Africa: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 70. South and Central America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 71. South and Central America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 72. South and Central America: Small Intestinal Bacterial Overgrowth (SIBO) diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 73. Brazil: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 74. Brazil: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 75. Brazil: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 76. Argentina: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 77. Argentina: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 78. Argentina: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 79. Rest of South and Central America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 80. Rest of South and Central America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 81. Rest of South and Central America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 82. Organic Developments Done by Companies
Table 83. Inorganic Developments Done by Companies
Table 84. Glossary of Terms, Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market
LIST OF FIGURES
Figure 1. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Segmentation
Figure 2. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – By Geography
Figure 3. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Overview
Figure 4. Breath Test Segment Held Largest Share of Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market by Diagnosis
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Geography (US$ Thousand)
Figure 7. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Leading Country Markets (US$ Thousand)
Figure 8. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. APAC: PEST Analysis
Figure 12. MEA: PEST Analysis
Figure 13. SCAM: PEST Analysis
Figure 14. Expert Opinion
Figure 15. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Impact Analysis of Drivers and Restraints
Figure 16. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue Forecast and Analysis – 2020- 2028
Figure 17. Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – By Geography Forecast and Analysis – 2020- 2028
Figure 18. Market Positioning of Key Players in Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market
Figure 19. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis 2020 & 2028 (%)
Figure 20. Breath Testing: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 21.C Xylose Breath Test: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 22. Hydrogen Breath Tests: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 23.C Glycocholic Acid Breath: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 24. Malabsorption Tests: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 25. Small Intestine Aspirate and Fluid Culture Test: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 26. Blood Test: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 27. Others: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 28. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type 2020 & 2028 (%)
Figure 29. Hydrogen-predominant SIBO: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 30. Methane-predominant SIBO: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 31. Recurrent SIBO: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 32. North America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Key Country – Revenue (2020) (USD Thousand)
Figure 33. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Revenue and Forecast to 2027 (USD Thousand)
Figure 34. North America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Country, 2020 & 2028 (%)
Figure 35. US: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 36. Canada: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 37. Mexico: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 38. Europe: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Key Country – Revenue (2020) (USD Thousand)
Figure 39. Europe Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Revenue and Forecast to 2027 (USD Thousand)
Figure 40. Europe: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Country, 2020 & 2028 (%)
Figure 41. Germany: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 42. UK: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 43. France: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 44. Italy: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 45. Spain: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 46. Rest of Europe: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 47. Asia Pacific: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Key Country – Revenue (2020) (USD Thousand)
Figure 48. Asia Pacific Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Revenue and Forecast to 2027 (USD Thousand)
Figure 49. Asia Pacific: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Country, 2020 & 2028 (%)
Figure 50. Japan: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 51. China: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 52. India: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 53. Australia: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 54. South Korea: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 55. Rest of Asia Pacific: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 56. Middle East and Africa: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Key Country – Revenue (2020) (USD Thousand)
Figure 57. Middle East and Africa Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Revenue and Forecast to 2027 (USD Thousand)
Figure 58. Middle East and Africa: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Country, 2020 & 2028 (%)
Figure 59. Saudi Arabia: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 60. UAE: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 61. South Africa: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 62. Rest of Middle East and Africa: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 63. South and Central America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Key Country – Revenue (2020) (USD Thousand)
Figure 64. South and Central America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Revenue and Forecast to 2027 (USD Thousand)
Figure 65. South and Central America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Country, 2020 & 2028 (%)
Figure 66. Brazil: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 67. Argentina: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 68. Rest of South and Central America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 69. Impact of COVID-19 Pandemic in North American Country Markets
Figure 70. Impact of COVID-19 Pandemic in European Country Markets
Figure 71. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 72. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 73. Impact of COVID-19 Pandemic in South and Central America Country Markets
Figure 74. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market
- Genova Diagnostics
- SIBO Diagnostics
- Commonwealth Diagnostics International
- Aerodiagnostics, LLC
- SIBOTest
- Metabolic Solutions, Inc.
- Pivotal Diagnostics
- DirectLabs, LLC
- Vibrant Wellness
- Health Associates Medical Group
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market
Mar 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Mar 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Mar 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Mar 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Mar 2021